VoltaXplore Inc., a Joint Venture Between NanoXplore and Martinrea, Announces Commissioning of Demonstration Facility and Battery Day Investor Event on April 5

VoltaXplore Inc., a 5050 joint venture between Martinrea International Inc. (TSX : MRE) and NanoXplore Inc. (TSX : GRA) aimed at commercializing the production of graphene-enhanced lithium-ion batteries for the electric vehicle market, today announced the commissioning of its one megawatt-hour demonstration facility in Montreal, Quebec. The facility is producing batteries, which are currently being optimized. The company expects graphene-enhanced batteries will have several advantages over existing products in the market today, such as greater capacity, increased battery life, faster charging speeds, and improved safety. Tests aimed at validating these benefits are ongoing, with encouraging results to date.

VoltaXplore will host Battery Day on April 5, 2022, in Montreal. Battery Day is an investor event that will showcase VoltaXplore's demonstration facility including its equipment and production processes and provide an opportunity for technical discussions and presentations with representatives from VoltaXplore, including senior management.

"VoltaXplore is making great progress and is on track toward meeting its expected milestones," said Pat D'Eramo, Chairman of VoltaXplore and President and CEO of Martinrea. "We remain excited about the venture, as we believe graphene-enhanced batteries have the potential to be a differentiated technology that could go a long way in addressing concerns around range and safety currently preventing more wide-scale adoption of electric vehicles. From Martinrea's perspective, combining our advanced lightweighting technologies with graphene-enhanced batteries is a big step forward in the EV space."

"I am delighted we joined a small group of companies in North America that are producing Li-ion batteries," said Soroush Nazarpour, President & CEO of VoltaXplore and NanoXplore. "Our focus is to integrate the supply chain of batteries in North America, which is of great interest to customers of batteries. Now that the facility is commissioned on-time and on-budget with satisfactory battery performance results, we are moving forward on optimizing our battery design for the electric vehicle market through testing with customers."

About VoltaXplore

VoltaXplore is a 50/50 joint venture between Martinrea International Inc. and NanoXplore Inc. aimed at commercializing and developing graphene-enhanced lithium-ion batteries for the electric vehicle market. VoltaXplore was established on April 15, 2021. Please visit www.voltaxplore.com .

About Martinrea International Inc.
Martinrea is a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems. Martinrea operates in 57 locations in Canada, the United States, Mexico, Brazil, Germany, Slovakia, Spain, China, South Africa and Japan. Martinrea's vision is making lives better by being the best supplier we can be in the products we make and the services we provide. For more information on Martinrea, please visit www.martinrea.com . Follow Martinrea on Twitter and Facebook .

About NanoXplore Inc.

NanoXplore is a graphene company, a manufacturer and supplier of high-volume graphene powder for use in transportation and industrial markets. The Company provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors. NanoXplore is headquartered in Montreal, Quebec with manufacturing facilities across North America and Europe. Please visit www.nanoxplore.ca .

For further information, please contact:

NANOXPLORE CONTACT:
Soroush Nazarpour, President & CEO
NanoXplore Inc.
info@NanoXplore.ca
Tel: 514.935.1377

MARTINREA CONTACT:
Deanna Lorincz, Global Director, Communications and Marketing
Martinrea International Inc.
deanna.lorincz@martinrea.com
Tel: 248.392.9727
Mobile: 586.634.1766


News Provided by GlobeNewswire via QuoteMedia

GRA:CA,NNXPF
The Conversation (0)
Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Contract manufacturing services as a new business line has the potential to generate approximately $4-5 million in annual revenues First manufacturing services contract signed with Secretome Therapeutics Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company... Keep Reading...
Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce an innovative research initiative to be undertaken with The Giacomantonio Immuno-Oncology Research Group (the "Research Group"). This study aims to evaluate the efficacy of Sona's Targeted... Keep Reading...
Why Invest in Nanotech Stocks?

Why Invest in Nanotech Stocks?

The nanotechnology market is experiencing a promising stage of growth, making it an attractive space for investors.From nanotech-based solar panels that increase energy efficiency to pharmaceutical products that make use of nanotech in drug-delivery systems, nanotechnology has far-reaching... Keep Reading...

SILO Pharma Inc

SILO Pharma Inc is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. Keep Reading...
Satellos Bioscience Inc.

Satellos Bioscience Inc.

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this... Keep Reading...
Vaxcyte Inc.

Vaxcyte Inc.

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. Keep Reading...

Interactive Chart

Latest Press Releases

Related News